Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore Abraham

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Plos One|August 4, 2012
In hypertrophic cardiomyopathy reduction of relative resting myocardial blood flow is related to late enhancement, T2-signal and LV wall thicknessKatja Hueper, Antonia Zapf, Jan Skrok, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|September 4, 2013
Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular AnesthesiologistsRebecca T Hahn, Theodore Abraham, Mark S Adams, et al.
Journal of the American College of Cardiology|March 25, 2026
Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy: Baseline Characteristics, Drug Exposure, and Outcomes in an Exploratory Analysis From ODYSSEY-HCMMilind Y Desai, Anjali Owens, Pablo Garcia-Pavia, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|September 5, 2025
Guidelines for the Standardization of Adult Echocardiography Reporting: Recommendations From the American Society of EchocardiographyCynthia C Taub, Raymond F Stainback, Theodore Abraham, et al.
Circulation|December 14, 2005
Arrhythmogenic right ventricular dysplasia: a United States experienceDarshan Dalal, Khurram Nasir, Chandra Bomma, et al.
Journal of the American College of Cardiology|July 31, 2007
Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathyDarshan Dalal, Rahul Jain, Harikrishna Tandri, et al.
Circulation|March 22, 2006
Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2Darshan Dalal, Lorraine H Molin, Jonathan Piccini, et al.
JACC. Cardiovascular Imaging|April 10, 2009
Cardiac magnetic resonance assessment of dyssynchrony and myocardial scar predicts function class improvement following cardiac resynchronization therapyKenneth C Bilchick, Veronica Dimaano, Katherine C Wu, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
ALPK3 heterozygous truncating variants cause late-onset hypertrophic cardiomyopathy with frequent apical involvement and apical aneurysmLeora Busse, Emily A Huth, Maria Roselle Abraham, et al.
Circulation. Genomic and Precision Medicine|June 5, 2025
ALPK3 Heterozygous Truncating Variants Cause Late-Onset Hypertrophic Cardiomyopathy With Frequent Apical Involvement and Apical AneurysmLeora Busse, Emily A Huth, Maria Roselle Abraham, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Plos One|August 4, 2012
In hypertrophic cardiomyopathy reduction of relative resting myocardial blood flow is related to late enhancement, T2-signal and LV wall thicknessKatja Hueper, Antonia Zapf, Jan Skrok, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|September 4, 2013
Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular AnesthesiologistsRebecca T Hahn, Theodore Abraham, Mark S Adams, et al.
Journal of the American College of Cardiology|March 25, 2026
Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy: Baseline Characteristics, Drug Exposure, and Outcomes in an Exploratory Analysis From ODYSSEY-HCMMilind Y Desai, Anjali Owens, Pablo Garcia-Pavia, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|September 5, 2025
Guidelines for the Standardization of Adult Echocardiography Reporting: Recommendations From the American Society of EchocardiographyCynthia C Taub, Raymond F Stainback, Theodore Abraham, et al.
Circulation|December 14, 2005
Arrhythmogenic right ventricular dysplasia: a United States experienceDarshan Dalal, Khurram Nasir, Chandra Bomma, et al.
Journal of the American College of Cardiology|July 31, 2007
Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathyDarshan Dalal, Rahul Jain, Harikrishna Tandri, et al.
Circulation|March 22, 2006
Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2Darshan Dalal, Lorraine H Molin, Jonathan Piccini, et al.
JACC. Cardiovascular Imaging|April 10, 2009
Cardiac magnetic resonance assessment of dyssynchrony and myocardial scar predicts function class improvement following cardiac resynchronization therapyKenneth C Bilchick, Veronica Dimaano, Katherine C Wu, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
ALPK3 heterozygous truncating variants cause late-onset hypertrophic cardiomyopathy with frequent apical involvement and apical aneurysmLeora Busse, Emily A Huth, Maria Roselle Abraham, et al.
Circulation. Genomic and Precision Medicine|June 5, 2025
ALPK3 Heterozygous Truncating Variants Cause Late-Onset Hypertrophic Cardiomyopathy With Frequent Apical Involvement and Apical AneurysmLeora Busse, Emily A Huth, Maria Roselle Abraham, et al.
Pageof 8